Clinical Trial Update: Slow-Release Oral Morphine for the Treatment of Opioid Use Disorder [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating slow-release oral morphine for opioid use disorder has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder
• Opioid-related Disorders

Drugs mentioned

• Slow-release oral morphine (morphine)

Snippet

Sponsor: M. Eugenia Socias | Conditions: Opioid-Related Disorders, Opiate Substitution Treatment | Phase 3 | Status: TERMINATED